Log in to save to my catalogue

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospe...

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69040487

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

About this item

Full title

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

Publisher

England: Elsevier Limited

Journal title

The lancet oncology, 2007-12, Vol.8 (12), p.1079-1087

Language

English

Formats

Publication information

Publisher

England: Elsevier Limited

More information

Scope and Contents

Contents

SummaryBackgroundA microarray-based 70-gene prognosis signature might improve the selection of patients with node-negative breast cancer for adjuvant systemic treatment. The main aims of this MicroarRAy PrognoSTics in Breast CancER (RASTER) study were to assess prospectively the feasibility of implementation of the 70-gene prognosis signature in co...

Alternative Titles

Full title

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_69040487

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69040487

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(07)70346-7

How to access this item